Companhia Paranaense de Energia SA (CPLE6):企業の財務・戦略的SWOT分析

◆英語タイトル:Companhia Paranaense de Energia SA (CPLE6) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C9191
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:エネルギー
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Companhia Paranaense de Energia SA (CPLE6) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Companhia Paranaense de Energia SA (Copel) is an integrated electric utility. It generates, transmits, distributes and sells electricity. The company produces electricity from hydro, wind, and thermal sources. Copel explores oil and natural gas; and distributes natural gas. It holds rights to supply piped gas in the State of Parana. Copel holds right to explore, research, develop, and produce oil and natural gas in four blocks in the central southern region of the State of Parana. The company also provides telecommunications and general communications services. Copel is headquartered in Curitiba, Parana,Brazil.

Companhia Paranaense de Energia SA Key Recent Developments

Sep 19,2018: Start of test operation of the Cutia Wind Complex
May 16,2018: Copel records EBITDA of R$767.8 million in the first quarter
Apr 13,2018: Copel records EBITDA of R$521.8 million in the fourth quarter
Feb 02,2018: Copel Distribuicao was awarded as the best distribution company in Brazil
Nov 29,2017: Copel records EBITDA of R$643.7 million in the third quarter

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Companhia Paranaense de Energia SA – Key Facts 6
Companhia Paranaense de Energia SA – Key Employees 7
Companhia Paranaense de Energia SA – Major Products and Services 8
Companhia Paranaense de Energia SA – History 9
Companhia Paranaense de Energia SA – Company Statement 11
Companhia Paranaense de Energia SA – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Companhia Paranaense de Energia SA – Business Description 15
Business Segment: COM 15
Overview 15
Performance 15
Business Segment: DIS 15
Overview 15
Performance 15
Key Stats 15
Business Segment: Gas 15
Overview 15
Performance 15
Key Stats 16
Business Segment: GeT 16
Overview 16
Performance 16
Key Stats 16
Business Segment: HOL 16
Overview 16
Business Segment: TEL 16
Overview 16
Performance 16
Key Stats 16
R&D Overview 17
Companhia Paranaense de Energia SA – SWOT Analysis 18
SWOT Analysis – Overview 18
Companhia Paranaense de Energia SA – Strengths 18
Companhia Paranaense de Energia SA – Weaknesses 19
Companhia Paranaense de Energia SA – Opportunities 20
Companhia Paranaense de Energia SA – Threats 21
Companhia Paranaense de Energia SA – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Company’s Power Financial Deals and Alliances 30
Companhia Paranaense de Energia SA, Power, Deals By Year, 2012 to YTD 2018 30
Companhia Paranaense de Energia SA, Power, Deals By Type, 2012 to YTD 2018 31
Companhia Paranaense de Energia SA, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
Sep 19, 2018: Start of test operation of the Cutia Wind Complex 33
May 16, 2018: Copel records EBITDA of R$767.8 million in the first quarter 34
Apr 13, 2018: Copel records EBITDA of R$521.8 million in the fourth quarter 35
Apr 13, 2018: Copel records EBITDA of R$521.8 million in the fourth quarter 36
Feb 02, 2018: Copel Distribuicao was awarded as the best distribution company in Brazil 37
Nov 29, 2017: Copel records EBITDA of R$643.7 million in the third quarter 38
Oct 19, 2017: Sao Miguel do Gostoso wind farm opens in Rio Grande do Norte 39
Jun 13, 2017: K2 Management obtains 12-month contract for 181MW phase 1 of Cutia Complex onshore wind farm, Brazil 40
Mar 22, 2017: Copel has a new CEO 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Companhia Paranaense de Energia SA, Key Facts 6
Companhia Paranaense de Energia SA, Key Employees 7
Companhia Paranaense de Energia SA, Major Products and Services 8
Companhia Paranaense de Energia SA, History 9
Companhia Paranaense de Energia SA, Subsidiaries 13
Companhia Paranaense de Energia SA, Key Competitors 22
Companhia Paranaense de Energia SA, Ratios based on current share price 23
Companhia Paranaense de Energia SA, Annual Ratios 24
Companhia Paranaense de Energia SA, Annual Ratios (Cont...1) 25
Companhia Paranaense de Energia SA, Annual Ratios (Cont...2) 26
Companhia Paranaense de Energia SA, Interim Ratios 28
Companhia Paranaense de Energia SA, Power, Deals By Year, 2012 to YTD 2018 30
Companhia Paranaense de Energia SA, Power, Deals By Type, 2012 to YTD 2018 31
Companhia Paranaense de Energia SA, Recent Deals Summary 32
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

List of Figures
Companhia Paranaense de Energia SA, Performance Chart (2013 - 2017) 27
Companhia Paranaense de Energia SA, Ratio Charts 29
Companhia Paranaense de Energia SA, Power, Deals By Year, 2012 to YTD 2018 30
Companhia Paranaense de Energia SA, Power, Deals by Type, 2012 to YTD 2018 31

★海外企業調査レポート[Companhia Paranaense de Energia SA (CPLE6):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OncBioMune Pharmaceuticals Inc (OBMP):企業の財務・戦略的SWOT分析
    Summary OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as renal, breast, prostrate, and ovarian cancer. It …
  • Antaros Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Antaros Medical AB (Antaros Medical) is a drug development and technology company that offers innovative MRI and PET imaging techniques for decision making in clinical drug development. The company's services include small- to medium-sized studies, decision-making in Phase 1b and Phase 2 tri …
  • Mabuhay Vinyl Corp (MVC):企業の財務・戦略的SWOT分析
    Mabuhay Vinyl Corp (MVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • JGC Corporation (1963):電力:M&Aディール及び事業提携情報
    Summary JGC Corporation (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power …
  • Bill & Melinda Gates Foundation:企業のM&A・事業提携・投資動向
    Bill & Melinda Gates Foundation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bill & Melinda Gates Foundation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Mmi Holdings Ltd.
    Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vallourec Sa:企業の戦略・SWOT・財務分析
    Vallourec Sa - Strategy, SWOT and Corporate Finance Report Summary Vallourec Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • AVJennings Limited:企業の戦略・SWOT・財務情報
    AVJennings Limited - Strategy, SWOT and Corporate Finance Report Summary AVJennings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Laboratoire Aguettant SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoire Aguettant (Aguettant) is a pharmaceutical company that offers development, manufacturing and commercialisation of essential hospital medicines. The company offers products under various categories such as specialist sectors and delivery systems. Its speciality sector offers emerg …
  • The Madison Square Garden Co:企業の戦略・SWOT・財務情報
    The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report Summary The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • The Medicines Company (MDCO)-医療機器分野:企業M&A・提携分析
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products, namely, Angiomax (bivalirudin), Orbactiv (oritavancin), Minocin (minocycl …
  • Nipro Corp (8086)-医療機器分野:企業M&A・提携分析
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceutical, medical and glass products. The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type …
  • Sigma-Tau HealthScience USA, Inc:戦略・SWOT・企業財務分析
    Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report Summary Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析
    Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sanofi (SAN)-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human v …
  • Voyager Therapeutics Inc (VYGR):企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • Intrasense SA (ALINS):企業の財務・戦略的SWOT分析
    Summary Intrasense SA (Intrasense) is a healthcare technology company that offers software solution for analysis and visualisation of medical images. The company offers a range of clinical apps such as lesion tracking solution, analysis tools, virtual colonoscopy, and lung nodule follow-up software, …
  • Alnylam Pharmaceuticals Inc (ALNY):製薬・医療:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Capio AB:企業の戦略・SWOT・財務情報
    Capio AB - Strategy, SWOT and Corporate Finance Report Summary Capio AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Unimedic AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆